Two Rare Disease-Associated Tyk2 Variants Are Catalytically Impaired but Signaling Competent
Open Access
- 1 March 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 190 (5) , 2335-2344
Abstract
Tyk2 belongs to the Janus protein tyrosine kinase family and is involved in signaling of immunoregulatory cytokines (type I and III IFNs, IL-6, IL-10, and IL-12 families) via its interaction with shared receptor subunits. Depending on the receptor complex, Tyk2 is coactivated with either Jak1 or Jak2, but a detailed molecular characterization of the interplay between the two enzymes is missing. In human populations, the Tyk2 gene presents high levels of genetic diversity with >100 nonsynonymous variants being detected. In this study, we characterized two rare Tyk2 variants, I684S and P1104A, which have been associated with susceptibility to autoimmune disease. Specifically, we measured their in vitro catalytic activity and their ability to mediate Stat activation in fibroblasts and genotyped B cell lines. Both variants were found to be catalytically impaired but rescued signaling in response to IFN-α/β, IL-6, and IL-10. These data, coupled with functional study of an engineered Jak1 P1084A, support a model of nonhierarchical activation of Janus kinases in which one catalytically competent Jak is sufficient for signaling provided that its partner behaves as proper scaffold, even if inactive. Through the analysis of IFN-α and IFN-γ signaling in cells with different Jak1 P1084A levels, we also illustrate a context in which a hypomorphic Jak can hamper signaling in a cytokine-specific manner. Given the multitude of Tyk2-activating cytokines, the cell context–dependent requirement for Tyk2 and the catalytic defect of the two disease-associated variants studied in this paper, we predict that these alleles are functionally significant in complex immune disorders.Keywords
This publication has 57 references indexed in Scilit:
- Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosisNature Genetics, 2012
- A Patient with Tyrosine Kinase 2 Deficiency without Hyper-IgE SyndromeThe Journal of Pediatrics, 2012
- Constitutive Type I Interferon Modulates Homeostatic Balance through Tonic SignalingImmunity, 2012
- Suppression of Cytokine Signaling by SOCS3: Characterization of the Mode of Inhibition and the Basis of Its SpecificityImmunity, 2012
- A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosisEuropean Journal of Human Genetics, 2009
- Multiple sclerosis susceptibility alleles in African AmericansGenes & Immunity, 2009
- Strong Evidence of a Combination Polymorphism of the Tyrosine Kinase 2 Gene and the Signal Transducer and Activator of Transcription 3 Gene as a DNA-Based Biomarker for Susceptibility to Crohn’s Disease in the Japanese PopulationJournal of Clinical Immunology, 2009
- Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factorEuropean Journal of Human Genetics, 2009
- Diverse Genome-wide Association Studies Associate the IL12/IL23 Pathway with Crohn DiseaseThe American Journal of Human Genetics, 2009
- An Allosteric Mechanism for Activation of the Kinase Domain of Epidermal Growth Factor ReceptorCell, 2006